Additionally, BMSCs‐EXOControl treatment increased FTO expression and decreased OXSR1 expression in CLP‐induced SA‐AKI mice models, and BMSCs‐EXOCurcumin could further aggravate this effect (Figure 6G). The gene discussed is OXSR1; the disease is acute kidney injury.